Dennis T. Brown
Corporate Officer/Principal bij North Carolina State University
Profiel
Dennis T.
Brown is the founder of Arbovax, Inc. founded in 2005.
Currently, he is a Professor & Head-Molecular at North Carolina State University since 1997.
Previously, he worked as an Assistant Professor at Dartmouth College, a Professor-Microbiology at The University of Texas at Austin, an Associate Professor-Medical Pharmacology at the University of Maryland, and a Professor-Genetics at Universität zu Köln.
He received his doctorate degree from the University of Pennsylvania in 1967.
Actieve functies van Dennis T. Brown
| Bedrijven | Functie | Begin |
|---|---|---|
| North Carolina State University | Corporate Officer/Principal | 01-01-1997 |
Eerdere bekende functies van Dennis T. Brown
| Bedrijven | Functie | Einde |
|---|---|---|
| The University of Texas at Austin | Corporate Officer/Principal | - |
| Universität zu Köln | Corporate Officer/Principal | - |
| Dartmouth College | Corporate Officer/Principal | - |
| University of Maryland | Corporate Officer/Principal | - |
Arbovax, Inc.
 Arbovax, Inc. Pharmaceuticals: MajorHealth Technology Arbovax, Inc. engages in the research and development of vaccines against arthropod-borne diseases. The firm facilitates development of vaccines against insect-borne viruses and focuses on dengue fever, chikungunya fever, west Nile virus, and veterinary markets. The company was founded by Malcolm E. Thomas, Jonathan Lawrie, Brown T. Dennis and Raquel Hernandez in October 2005 and is headquartered in Raleigh, NC. | Oprichter | - |
Opleiding van Dennis T. Brown
| University of Pennsylvania | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Arbovax, Inc.
Arbovax, Inc. Pharmaceuticals: MajorHealth Technology Arbovax, Inc. engages in the research and development of vaccines against arthropod-borne diseases. The firm facilitates development of vaccines against insect-borne viruses and focuses on dengue fever, chikungunya fever, west Nile virus, and veterinary markets. The company was founded by Malcolm E. Thomas, Jonathan Lawrie, Brown T. Dennis and Raquel Hernandez in October 2005 and is headquartered in Raleigh, NC. | Health Technology |